Share

September 2017; 4 (5)

Share

A

  1. Abreu, Pedro

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  2. Alusi, Sundus

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  3. Alves, Joana

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  4. Annovazzi, Pietro

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

B

  1. Bandini, Fabio

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

  2. Barker, Erandi

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  3. Bittner, Frank

    1. Open Access
      Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS
      Frank Bittner, Charles Murchison, Dennis Koop, Dennis Bourdette, Rebecca Spain

  4. Bonello, Michael

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  5. Bourdette, Dennis

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette
    2. Open Access
      Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS
      Frank Bittner, Charles Murchison, Dennis Koop, Dennis Bourdette, Rebecca Spain

  6. Brodsky, Robert A.

    1. Open Access
      High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
      Christopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, Lisa Christopher-Stine

C

  1. Cameron, Michelle

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  2. Cavalier, Steve

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  3. Cheng, Bastian

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  4. Chhabra, Richa

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  5. Christopher-Stine, Lisa

    1. Open Access
      High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
      Christopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, Lisa Christopher-Stine

  6. Costa, Andreia

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

D

  1. Dalmau, Josep

    1. Open Access
      Shifting paradigms
      Josep Dalmau

  2. Derfuss, Tobias

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  3. De Stefano, Nicola

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano

  4. Dewey, Blake E.

    1. Open Access
      MRI evaluation of thalamic volume differentiates MS from common mimics
      Andrew J. Solomon, Richard Watts, Blake E. Dewey, Daniel S. Reich

  5. Donaldson, Jessica E.

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  6. Dumitrascu, Oana M.

    1. Open Access
      Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
      Oana M. Dumitrascu, Andrew McKeon, Leslie Zuniga, Marie F. Grill, Brent P. Goodman

E

  1. Ellul, Mark A.

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  2. Engel, Casey

    1. Open Access
      Glucocorticoid-associated blood glucose response and MS relapse recovery
      Myla D. Goldman, Scott Koenig, Casey Engel, Christopher R. McCartney, Min-Woong Sohn

F

  1. Fechner, Kai

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

G

  1. Gadoth, Avi

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  2. Gaetano, Laura

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  3. Gananandan, Kohilan

    1. Open Access
      Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF
      Salwa Kamourieh, Kohilan Gananandan, Joel Raffel, Richard Nicholas

  4. Gerloff, Christian

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  5. Ghezzi, Angelo

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

  6. Goldman, Myla D.

    1. Open Access
      Glucocorticoid-associated blood glucose response and MS relapse recovery
      Myla D. Goldman, Scott Koenig, Casey Engel, Christopher R. McCartney, Min-Woong Sohn

  7. Goodman, Brent P.

    1. Open Access
      Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
      Oana M. Dumitrascu, Andrew McKeon, Leslie Zuniga, Marie F. Grill, Brent P. Goodman

  8. Graus, Francesc

    1. Open Access
      Understanding anti-IgLON5 disease
      Francesc Graus, Joan Santamaría

  9. Grill, Marie F.

    1. Open Access
      Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
      Oana M. Dumitrascu, Andrew McKeon, Leslie Zuniga, Marie F. Grill, Brent P. Goodman

H

  1. Heesen, Christoph

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  2. Heriza, Elizabeth

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  3. Hilgetag, Claus

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  4. Hinson, Shannon R.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  5. Hodecker, Sibylle

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  6. Honorat, Josephe A.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  7. Horak, Fay

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

J

  1. Jacob, Anu

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  2. Jefferson, Samantha

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  3. Jones, Dallas

    1. Open Access
      Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
      Dallas Jones, C. Preston Neff, Brent E. Palmer, Kurt Stenmark, Maria A. Nagel

  4. Josephs, Keith A.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

K

  1. Kamourieh, Salwa

    1. Open Access
      Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF
      Salwa Kamourieh, Kohilan Gananandan, Joel Raffel, Richard Nicholas

  2. Kappos, Ludwig

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos
    2. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  3. Kim, Ed

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  4. Knudsen, Stine

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

  5. Koenig, Scott

    1. Open Access
      Glucocorticoid-associated blood glucose response and MS relapse recovery
      Myla D. Goldman, Scott Koenig, Casey Engel, Christopher R. McCartney, Min-Woong Sohn

  6. Komorowski, Lars

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  7. Koop, Dennis

    1. Open Access
      Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS
      Frank Bittner, Charles Murchison, Dennis Koop, Dennis Bourdette, Rebecca Spain

  8. Kovarik, John M.

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  9. Kumar, Neeraj

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

L

  1. Lahouti, Arash H.

    1. Open Access
      High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
      Christopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, Lisa Christopher-Stine

  2. Lang, Katharina

    1. Open Access
      Frequencies of neuronal autoantibodies in healthy controlsEstimation of disease specificity
      Katharina Lang, Harald Prüss

  3. Lapucci, Caterina

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

  4. Lederer, Sabine

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  5. Lennon, Vanda A.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

M

  1. Mammen, Andrew L.

    1. Open Access
      High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
      Christopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, Lisa Christopher-Stine

  2. Mancardi, Giovanni L.

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

  3. Martínez-Hernández, Eugenia

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  4. McCartney, Christopher R.

    1. Open Access
      Glucocorticoid-associated blood glucose response and MS relapse recovery
      Myla D. Goldman, Scott Koenig, Casey Engel, Christopher R. McCartney, Min-Woong Sohn

  5. McKeon, Andrew

    1. Open Access
      Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
      Oana M. Dumitrascu, Andrew McKeon, Leslie Zuniga, Marie F. Grill, Brent P. Goodman
    2. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  6. Mecoli, Christopher A.

    1. Open Access
      High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
      Christopher A. Mecoli, Arash H. Lahouti, Robert A. Brodsky, Andrew L. Mammen, Lisa Christopher-Stine

  7. Mueller-Lenke, Nicole

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  8. Murchison, Charles

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette
    2. Open Access
      Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS
      Frank Bittner, Charles Murchison, Dennis Koop, Dennis Bourdette, Rebecca Spain

N

  1. Nagel, Maria A.

    1. Open Access
      Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
      Dallas Jones, C. Preston Neff, Brent E. Palmer, Kurt Stenmark, Maria A. Nagel

  2. Neff, C. Preston

    1. Open Access
      Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
      Dallas Jones, C. Preston Neff, Brent E. Palmer, Kurt Stenmark, Maria A. Nagel

  3. Neves, Nélia

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  4. Nicholas, Richard

    1. Open Access
      Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF
      Salwa Kamourieh, Kohilan Gananandan, Joel Raffel, Richard Nicholas

  5. Nilsen, Kristian Bernhard

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

  6. Novi, Giovanni

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

P

  1. Palmer, Brent E.

    1. Open Access
      Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
      Dallas Jones, C. Preston Neff, Brent E. Palmer, Kurt Stenmark, Maria A. Nagel

  2. Panzara, Michael A.

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  3. Parker, Robert

    1. Open Access
      IgLON5 disease responsive to immunotherapy
      Michael Bonello, Anu Jacob, Mark A. Ellul, Erandi Barker, Robert Parker, Samantha Jefferson, Sundus Alusi

  4. Pittock, Sean J.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

  5. Pizzorno, Matteo

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

  6. Powers, Katherine

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  7. Prüss, Harald

    1. Open Access
      Frequencies of neuronal autoantibodies in healthy controlsEstimation of disease specificity
      Katharina Lang, Harald Prüss

R

  1. Radue, Ernst-Wilhelm

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  2. Raffel, Joel

    1. Open Access
      Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF
      Salwa Kamourieh, Kohilan Gananandan, Joel Raffel, Richard Nicholas

  3. Reich, Daniel S.

    1. Open Access
      MRI evaluation of thalamic volume differentiates MS from common mimics
      Andrew J. Solomon, Richard Watts, Blake E. Dewey, Daniel S. Reich

  4. Rufi, Pascal

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano

S

  1. Santamaría, Joan

    1. Open Access
      Understanding anti-IgLON5 disease
      Francesc Graus, Joan Santamaría

  2. Sarmento, António

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  3. Savelieva, Marina

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  4. Siemonsen, Susanne

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  5. Silva-Pinto, André

    1. Open Access
      Postmalaria neurologic syndrome associated with neurexin-3α antibodies
      Andreia Costa, André Silva-Pinto, Joana Alves, Nélia Neves, Eugenia Martínez-Hernández, Pedro Abreu, António Sarmento

  6. Simon, Jack

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  7. Simonson, Catherine

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano

  8. Sohn, Min-Woong

    1. Open Access
      Glucocorticoid-associated blood glucose response and MS relapse recovery
      Myla D. Goldman, Scott Koenig, Casey Engel, Christopher R. McCartney, Min-Woong Sohn

  9. Solomon, Andrew J.

    1. Open Access
      MRI evaluation of thalamic volume differentiates MS from common mimics
      Andrew J. Solomon, Richard Watts, Blake E. Dewey, Daniel S. Reich

  10. Soosai, Joseph

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

  11. Sormani, Maria Pia

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano

  12. Spain, Rebecca

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette
    2. Open Access
      Lipoic acid pharmacokinetics at baseline and 1 year in secondary progressive MS
      Frank Bittner, Charles Murchison, Dennis Koop, Dennis Bourdette, Rebecca Spain

  13. Sprenger, Till

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  14. Stellmann, Jan-Patrick

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  15. Stenmark, Kurt

    1. Open Access
      Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
      Dallas Jones, C. Preston Neff, Brent E. Palmer, Kurt Stenmark, Maria A. Nagel

  16. St Louis, Erik K.

    1. Open Access
      IgLON5 antibodyNeurological accompaniments and outcomes in 20 patients
      Josephe A. Honorat, Lars Komorowski, Keith A. Josephs, Kai Fechner, Erik K. St Louis, Shannon R. Hinson, Sabine Lederer, Neeraj Kumar, Avi Gadoth, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon

T

  1. Thakur, Avinash

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  2. Thangavelu, Karthinathan

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano
    2. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  3. Thomalla, Götz

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  4. Thorsby, Per Medbøe

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

  5. Tomic, Davorka

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  6. Truffinet, Philippe

    1. Open Access
      Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
      Maria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, Pascal Rufi, Catherine Simonson, Nicola De Stefano

U

  1. Uccelli, Antonio

    1. Open Access
      Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
      Giovanni Novi, Angelo Ghezzi, Matteo Pizzorno, Caterina Lapucci, Fabio Bandini, Pietro Annovazzi, Giovanni L. Mancardi, Antonio Uccelli

V

  1. Vikin, Truls

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

  2. Viste, Rannveig

    1. Open Access
      Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
      Rannveig Viste, Joseph Soosai, Truls Vikin, Per Medbøe Thorsby, Kristian Bernhard Nilsen, Stine Knudsen

W

  1. Wanke, Nadine

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

  2. Watts, Richard

    1. Open Access
      MRI evaluation of thalamic volume differentiates MS from common mimics
      Andrew J. Solomon, Richard Watts, Blake E. Dewey, Daniel S. Reich

  3. Wiendl, Heinz

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  4. Winges, Kimberly

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  5. Wolinsky, Jerry S.

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  6. Woodward, Fiona M.

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

  7. Wuerfel, Jens

    1. Open Access
      Teriflunomide slows BVL in relapsing MSA reanalysis of the TEMSO MRI data set using SIENA
      Ernst-Wilhelm Radue, Till Sprenger, Laura Gaetano, Nicole Mueller-Lenke, Steve Cavalier, Karthinathan Thangavelu, Michael A. Panzara, Jessica E. Donaldson, Fiona M. Woodward, Jens Wuerfel, Jerry S. Wolinsky, Ludwig Kappos

Y

  1. Yadav, Vijayshree

    1. Open Access
      Lipoic acid in secondary progressive MSA randomized controlled pilot trial
      Rebecca Spain, Katherine Powers, Charles Murchison, Elizabeth Heriza, Kimberly Winges, Vijayshree Yadav, Michelle Cameron, Ed Kim, Fay Horak, Jack Simon, Dennis Bourdette

  2. Young, Kim Lea

    1. Open Access
      Reduced rich-club connectivity is related to disability in primary progressive MS
      Jan-Patrick Stellmann, Sibylle Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Hilgetag, Christian Gerloff, Christoph Heesen, Götz Thomalla, Susanne Siemonsen

Z

  1. Zhang, Ying

    1. Open Access
      α4-integrin receptor desaturation and disease activity return after natalizumab cessation
      Tobias Derfuss, John M. Kovarik, Ludwig Kappos, Marina Savelieva, Richa Chhabra, Avinash Thakur, Ying Zhang, Heinz Wiendl, Davorka Tomic

  2. Zuniga, Leslie

    1. Open Access
      Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
      Oana M. Dumitrascu, Andrew McKeon, Leslie Zuniga, Marie F. Grill, Brent P. Goodman
Back to top
Neurology - Neuroimmunology Neuroinflammation: 4 (5)
Subscribe to e-Alerts
RSS
Advertisement
Advertisement